These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32603068)

  • 1. Blood Product Transfusion in Adults: Indications, Adverse Reactions, and Modifications.
    Raval JS; Griggs JR; Fleg A
    Am Fam Physician; 2020 Jul; 102(1):30-38. PubMed ID: 32603068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
    Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
    Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.
    Harvey AR; Basavaraju SV; Chung KW; Kuehnert MJ
    Transfusion; 2015 Apr; 55(4):709-18. PubMed ID: 25371300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.
    Saadah NH; van der Bom JG; Wiersum-Osselton JC; Richardson C; Middelburg RA; Politis C; Renaudier P; Robillard P; Schipperus MR
    Br J Haematol; 2018 Mar; 180(5):727-734. PubMed ID: 29318576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninfectious transfusion-associated adverse events and their mitigation strategies.
    Goel R; Tobian AAR; Shaz BH
    Blood; 2019 Apr; 133(17):1831-1839. PubMed ID: 30808635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supportive transfusion therapy in cancer patients with acquired defects of hemostasis.
    Federici AB; Intini D; Lattuada A; Vanelli C; Arrigoni L; Sacchi E; Russo U
    Thromb Res; 2014 May; 133 Suppl 2():S56-62. PubMed ID: 24862147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.
    Oakley FD; Woods M; Arnold S; Young PP
    Transfusion; 2015 Mar; 55(3):563-70. PubMed ID: 25145580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse transfusion reactions in transfused children.
    Moncharmont P
    Transfus Clin Biol; 2019 Nov; 26(4):329-335. PubMed ID: 31563446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
    Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood derived products in pediatrics: New laboratory tools for optimizing potency assignment and reducing side effects.
    Amiral J; Seghatchian J
    Transfus Apher Sci; 2017 Apr; 56(2):107-117. PubMed ID: 28343935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses.
    Anglin CO; Spence JS; Warner MA; Paliotta C; Harper C; Moore C; Sarode R; Madden C; Diaz-Arrastia R
    J Neurosurg; 2013 Mar; 118(3):676-86. PubMed ID: 23259827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboelastometry versus standard coagulation tests versus restrictive protocol to guide blood transfusion prior to central venous catheterization in cirrhosis: study protocol for a randomized controlled trial.
    Rocha LL; Pessoa CM; Neto AS; do Prado RR; Silva E; de Almeida MD; Correa TD;
    Trials; 2017 Feb; 18(1):85. PubMed ID: 28241780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of blood products in pediatric cardiac surgery.
    Durandy Y
    Artif Organs; 2015 Jan; 39(1):21-7. PubMed ID: 25626576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?
    Gajic O; Dzik WH; Toy P
    Crit Care Med; 2006 May; 34(5 Suppl):S170-3. PubMed ID: 16617262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative bleeding management in pediatric patients.
    Goobie SM; Haas T
    Curr Opin Anaesthesiol; 2016 Jun; 29(3):352-8. PubMed ID: 26844864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cumulative risks of early fresh frozen plasma, cryoprecipitate and platelet transfusion in Europe.
    Norda R; Tynell E; Akerblom O
    J Trauma; 2006 Jun; 60(6 Suppl):S41-5. PubMed ID: 16763480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.